Microns, Memory

Micron's Memory Pipeline Is Sold Out Through 2028 — But the Stock Is Sitting Out the Party

Published on 08/21/2026 at 22:02 | Redaktion boerse-global.de

Micron's HBM capacity is fully booked through 2028, with $1B in HBM4 revenue already secured. Stock dips 0.7% despite record guidance.

Micron HBM4 Capacity Sold Out Through 2028, $1B Booked
Micron Technology Illustration mit AI erstellt übermittelt durch boerse-global.de

The semiconductor industry has a curious habit of making its most consequential announcements on days when the market barely shrugs. Micron Technology delivered one of those moments this week: the company's high-bandwidth memory capacity is fully booked for calendar 2026, with demand for both HBM3E and its successor HBM4 stretching all the way to 2028. Shares, however, drifted lower by 0.7 percent on Friday, settling at 829.90 euros — roughly 1.8 percent beneath the 50-day moving average of 844.87 euros.

The muted reaction suggests investors had already priced in the supply squeeze, or were simply taking profits after a blistering run that has left the stock trading about 25 percent below its 52-week high despite a 728 percent gain over the past year.

A Billion-Dollar Head Start on HBM4

The capacity sell-out is backed by a striking commercial milestone: Micron has already booked more than one billion dollars in revenue from HBM4 chips. Management says the ramp of its 12-layer HBM4 stacks is progressing twice as fast as the previous generation, HBM3E — a signal that the company is closing the technology gap with SK Hynix and Samsung, the other two players dominating the advanced memory market.

That demand visibility extends well beyond the immediate horizon. The company's guidance for the fourth fiscal quarter of 2026 points to record revenue of roughly 50 billion dollars and non-GAAP earnings per share between 30.00 and 32.00 dollars, underpinned by 16 strategic customer agreements carrying a minimum volume of 100 billion dollars through 2030.

Spending Big to Stay Ahead

The commercial momentum is being matched by an aggressive capital deployment strategy. This week, Micron opened its "Micron Research Labs" in Boise, Idaho, a facility backed by a planned ten billion dollars in investment over the coming decade. The lab will focus on new memory architectures for AI applications and advanced packaging technologies — areas where the company believes it can differentiate itself beyond the cyclical DRAM and NAND businesses.

Should investors sell immediately? Or is it worth buying Micron Technology?

The research push is flanked by other moves. Micron is investing 500 million dollars in GlobalWafers to build a silicon wafer factory in Texas, a component of the company's broader 250 billion dollar US manufacturing strategy. And in mid-August, Micron Ventures launched the "Paradigm Fund," a 250 million dollar vehicle dedicated to investments in startups across the AI technology stack.

The backing of Apple CEO Tim Cook and Nvidia CEO Jensen Huang for the new research center adds a layer of validation — the two biggest buyers of AI hardware have a direct interest in securing Micron's memory supply chain.

Insiders and Institutions Move in Different Directions

Not all the recent signals have been uniformly bullish. Sumit Sadana, Micron's chief business officer, sold 15,000 shares on Tuesday at a weighted average price of 934.29 dollars, a transaction worth roughly 14.01 million dollars. The sale was not conducted under a Rule 10b5-1 automated trading plan, which typically provides executives with a pre-arranged schedule for disposing of shares.

Institutional activity tells a mixed story. Halter Ferguson Financial cut its Micron position by 72 percent in the second quarter, leaving it with 18,140 shares valued at 20.9 million dollars. At the same time, Micron ranked among the most heavily added positions at Morgan Stanley and UBS during the same period — evidence that major asset managers are arriving at different conclusions about the current valuation.

Analysts Split on the Next Move

Wall Street's view is similarly divided. UBS analyst Timothy Arcuri reaffirmed a buy rating with a price target of 1,625.00 dollars, citing robust and sustainable earnings potential despite what he described as a "wall of worry" in the industry. BofA's Vivek Arya followed a day later, also maintaining a buy with a target of 1,550.00 dollars, and projects earnings per share above 230.00 dollars by fiscal 2030, driven by AI demand.

A more cautious note comes from 24/7 Wall St., which rates the stock a "Hold" with a price target of 964.63 dollars, arguing that after the year's substantial rally, the shares are fairly valued. Citigroup, meanwhile, lowered its price target in early August while keeping a buy recommendation, flagging potential pressure on DRAM and NAND pricing in 2027 as a possible headwind.

The September Test

The market's attention now turns to September 30, when Micron reports its fourth fiscal quarter and full-year 2026 results. Given the HBM demand visibility extending to 2028, the focus will likely fall on pricing trends in DRAM and NAND — the segments that will determine whether the company's billion-dollar bets on AI infrastructure are already translating into operational substance, or whether the investment narrative has temporarily run ahead of the fundamentals.

Ad

Micron Technology Stock: New Analysis - 21 August

Fresh Micron Technology information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Micron Technology analysis...

Disclaimer...

en | US5951121038 | MICRONS | boerse | 69983445 |